MannKind | MNKD - Market Capitalization


MannKind reported $1.09B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Insmed USD 35.3B 1.82B Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
MacroGenics USD 287M 103M Jul/2026
MannKind USD 757M 984M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.81B 12.24B Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Xencor USD 893M 200M Mar/2026